C12Y 204/01212
Hyaluronan synthase
Official title: Hyaluronan synthase (2.4.1.212)
C12Y204/01212 (Hyaluronan synthase) appears on 17 US grants and 28 published applications in this corpus.
Search patents in C12Y- Granted patents
- 17
- Published applications
- 28
- Assignees
- 20
- Inventors
- 52
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 2 | 1 |
| 2006 | 1 | 2 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 2 |
| 2017 | 1 | 1 |
| 2018 | 2 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 2 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Hyaluronic acid-producing recombinant cells14 Jul 2026US 12,680,121 B2Givaudan SA
- High-efficiency synthesis and high-purity hyaluronic acid, and recombinant Corynebacterium glutamicum for oligosaccharide thereof6 Aug 2024US 12,054,760 B2Bloomage Biotechnology Corporation Limited
- Recombinant AAV vectors expressing osteoprotective genes, including HAS2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals20 Feb 2024US 11,905,531 B2Boehringer Ingelheim Animal Health USA Inc.
- Self-regenerating hyaluronan polymer brushes13 Jul 2021US 11,060,074 B2Georgia Tech Research Corporation
- Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications20 Nov 2018US 10,131,717 B2London Health Sciences Centre Research Inc.
- Glucolipid production24 Sep 2026US 2026/0286284 A1Evonik Operations GmbH
- Hyaluronan synthesis, secretion and length control24 Sep 2026US 2026/0286413 A1University of Virginia
- Viscosity-tolerant corynebacterium glutamicum strain and use thereof11 Dec 2025US 2025/0376657 A1Jiangnan University
- Hyaluronic acid-producing recombinant cells8 May 2025US 2025/0146037 A1Givaudan SA
- Recombinant aav vectors expressing osteoprotective genes, including has2 and lubricin, useful in the treatment of osteoarthritis and related joint conditions in mammals1 Aug 2024US 2024/0254454 A1Genzyme Corporation
Most cited
By later US patents
- Hyaluronate synthase gene and uses thereof28US 6,455,304 B1The Board of Regents of the University of Oklahoma · 2002
- Antibody that specifically binds hyaluronan synthase13US 7,662,929 B2Alchemia Oncology Pty Limited · 2010
- Antibody that specifically binds hyaluronan synthase11US 7,985,844 B2Alchemia Oncology Pty Limited · 2011
- Hyaluronate synthase gene and uses thereof2US 6,855,502 B22005
- Hyaluronate synthase gene and uses thereof2US 7,026,159 B2The Board of Regents of the University of Oklahoma · 2006